Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 603

The DOI matches its Crossref record; 311 of the 311 references it cites were found in a registry or an index.

Is early-onset cancer an emerging global epidemic? Current evidence and future implications

Open access
Ugai, Tomotaka, Sasamoto, Naoko, Lee, Hwa-Young, Ando, Mariko, Song, Mingyang, Tamimi, Rulla M., Kawachi, Ichiro, Campbell, Peter T., Giovannucci, Edward L., Weiderpass, Elisabete, Rebbeck, Timothy R., Ogino, Shuji·2022·Nature Reviews Clinical Oncology

Abstract

Over the past several decades, the incidence of early-onset cancers, often defined as cancers diagnosed in adults <50 years of age, in the breast, colorectum, endometrium, oesophagus, extrahepatic bile duct, gallbladder, head and neck, kidney, liver, bone marrow, pancreas, prostate, stomach and thyroid has increased in multiple countries. Increased use of screening programmes has contributed to this phenomenon to a certain extent, although a genuine increase in the incidence of early-onset forms of several cancer types also seems to have emerged. Evidence suggests an aetiological role of risk factor exposures in early life and young adulthood. Since the mid-20th century, substantial multigenerational changes in the exposome have occurred (including changes in diet, lifestyle, obesity, environment and the microbiome, all of which might interact with genomic and/or genetic susceptibilities). However, the effects of individual exposures remain largely unknown. To study early-life exposures and their implications for multiple cancer types will require prospective cohort studies with dedicated biobanking and data collection technologies. Raising awareness among both the public and health-care professionals will also be critical. In this Review, we describe changes in the incidence of early-onset cancers globally and suggest measures that are likely to reduce the burden of cancers and other chronic non-communicable diseases. The incidence of early-onset forms of many cancers (defined as cancers diagnosed in individuals <50 years of age) has increased in a number of countries over the past several decades. The underlying reasons for this apparent increase probably include greater use of screening programmes, but also changing patterns in early-life exposures. In this Review, the authors describe the emerging global increase in the incidence of early-onset cancers and suggest changes that might address this situation. The incidence of cancers of various organs diagnosed in adults ≤50 years of age has been rising in many parts of the world since the 1990s. Evidence suggests an aetiological role for risk factor exposures in early life and young adulthood, although specific effects of individual exposures remain largely unknown. The early life exposome (including, among other factors, diet, lifestyle, obesity, environmental exposures and the microbiome) has changed substantially, with variable trends observed around the world since the mid-20th century. The early-onset cancer epidemic might be one manifestation of increasing trends in the development of many chronic diseases in young and future generations. Prospective cohort studies using electronic health records and/or early-life biospecimen collection would enable the detailed investigation of early-life factors in relation to many future health outcomes, including cancer. Raising awareness of the early-onset cancer epidemic and improving the early-life environment should be our immediate goals: these are likely to reduce the burden of both early-onset and later-onset cancers. The incidence of cancers of various organs diagnosed in adults ≤50 years of age has been rising in many parts of the world since the 1990s. Evidence suggests an aetiological role for risk factor exposures in early life and young adulthood, although specific effects of individual exposures remain largely unknown. The early life exposome (including, among other factors, diet, lifestyle, obesity, environmental exposures and the microbiome) has changed substantially, with variable trends observed around the world since the mid-20th century. The early-onset cancer epidemic might be one manifestation of increasing trends in the development of many chronic diseases in young and future generations. Prospective cohort studies using electronic health records and/or early-life biospecimen collection would enable the detailed investigation of early-life factors in relation to many future health outcomes, including cancer. Raising awareness of the early-onset cancer epidemic and improving the early-life environment should be our immediate goals: these are likely to reduce the burden of both early-onset and later-onset cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41571-022-00672-8

Cites

311 of 311 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 311 references

Research works printed but not linked: 40

  1. Giovannucci, E. A growing link – what is the role of height in cancer risk? Br. J. Cancer 120, 575–576 (2019). · doi:10.1038/s41416-018-0370-9
  2. Holmes, A. J. & Anderson, K. Convergence in national alcohol consumption patterns: new global indicators. J. Wine Econ. 12, 117–148 (2017). · doi:10.1017/jwe.2017.15
  3. IARC Working Group on the Identification of Carcinogenic Hazards to Humans. Night Shift Work Vol. 124 (IARC, 2020).
  4. Darroch, J. E. Trends in contraceptive use. Contraception 87, 259–263 (2013). · doi:10.1016/j.contraception.2012.08.029
  5. Bellanger, M., Lima, S. M., Cowppli-Bony, A., Molinie, F. & Terry, M. B. Effects of fertility on breast cancer incidence trends: comparing France and US. Cancer Causes Control. 32, 903–910 (2021). · doi:10.1007/s10552-021-01440-2
  6. Kropp, S., Becher, H., Nieters, A. & Chang-Claude, J. Low-to-moderate alcohol consumption and breast cancer risk by age 50 years among women in Germany. Am. J. Epidemiol. 154, 624–634 (2001). · doi:10.1093/aje/154.7.624
  7. Jung, Y. S., Park, C. H., Kim, N. H., Lee, M. Y. & Park, D. I. Impact of age on the risk of advanced colorectal neoplasia in a young population: an analysis using the predicted probability model. Dig. Dis. Sci. 62, 2518–2525 (2017). · doi:10.1007/s10620-017-4683-y
  8. Heikkinen, S. M. et al. Familial aggregation of early-onset cancers. Int. J. Cancer 146, 1791–1799 (2020). · doi:10.1002/ijc.32512
  9. Hall, N., Bishop, D., Stephenson, B. & Finan, P. Hereditary susceptibility to colorectal cancer. Dis. Colon Rectum 39, 739–743 (1996). · doi:10.1007/bf02054437
  10. Haidopoulos, D. et al. Risk factors in women 40 years of age and younger with endometrial carcinoma. Acta Obstet. Gynecol. Scand. 89, 1326–1330 (2010). · doi:10.3109/00016349.2010.515666
  11. Walsh, M. D. et al. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin. Cancer Res. 14, 1692–1700 (2008). · doi:10.1158/1078-0432.ccr-07-1849
  12. Drahos, J. et al. Age-specific risk factor profiles of adenocarcinomas of the esophagus: a pooled analysis from the international BEACON consortium. Int. J. Cancer 138, 55–64 (2016). · doi:10.1002/ijc.29688
  13. Nelson, S. P. et al. Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy. J. Med. Econ. 12, 348–355 (2009). · doi:10.3111/13696990903378680
  14. Hemminki, K. & Li, X. Age-specific familial risks for renal cell carcinoma with evidence on recessive heritable effects. Kidney Int. 65, 2298–2302 (2004). · doi:10.1111/j.1523-1755.2004.00650.x
  15. Park, C.-H. et al. Family history influences the early onset of hepatocellular carcinoma. World J. Gastroenterol. 18, 2661–2667 (2012). · doi:10.3748/wjg.v18.i21.2661
  16. Rebbeck, T. R. & Haas, G. P. Temporal trends and racial disparities in global prostate cancer prevalence. Can. J. Urol. 21, 7496–7506 (2014).
  17. Brandt, A., Bermejo, J. L., Sundquist, J. & Hemminki, K. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur. Urol. 58, 275–280 (2010). · doi:10.1016/j.eururo.2010.02.002
  18. Giryes, A., Oweira, H., Mannhart, M., Decker, M. & Abdel-Rahman, O. Exploring the differences between early-onset gastric cancer and traditional-onset gastric cancer. J. Gastrointest. Oncol. 9, 1157–1163 (2018). · doi:10.21037/jgo.2018.06.11
  19. Grönberg, H., Bergh, A., Damber, J. E. & Emanuelsson, M. Cancer risk in families with hereditary prostate carcinoma: a possible link between prostate, breast, and gastric carcinoma. Cancer 89, 1315–1321 (2000). · doi:10.1002/1097-0142(20000915)89:6<1315::aid-cncr17>3.0.co;2-8
  20. Fitzgerald, R. C. & Caldas, C. Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. Gut 53, 775–778 (2004). · doi:10.1136/gut.2003.022061
  21. Bacani, J. T. et al. CDH1/E-cadherin germline mutations in early-onset gastric cancer. J. Med. Genet. 43, 867–872 (2006). · doi:10.1136/jmg.2006.043133
  22. Murphy, B. L., Day, C. N., Hoskin, T. L., Habermann, E. B. & Boughey, J. C. Adolescents and young adults with breast cancer have more aggressive disease and treatment than patients in their forties. Ann. Surg. Oncol. 26, 3920–3930 (2019). · doi:10.1245/s10434-019-07653-9
  23. Tran, B. N., Connell, P. P., Waggoner, S., Rotmensch, J. & Mundt, A. J. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am. J. Clin. Oncol. 23, 476–480 (2000). · doi:10.1097/00000421-200010000-00009
  24. Pellerin, G. P. & Finan, M. A. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am. J. Obstet. Gynecol. 193, 1640–1644 (2005). · doi:10.1016/j.ajog.2005.05.003
  25. Quinn, M. A., Kneale, B. J. & Fortune, D. W. Endometrial carcinoma in premenopausal women: a clinicopathological study. Gynecol. Oncol. 20, 298–306 (1985). · doi:10.1016/0090-8258(85)90211-2
  26. Evans-Metcalf, E. R., Brooks, S. E., Reale, F. R. & Baker, S. P. Profile of women 45 years of age and younger with endometrial cancer. Obstet. Gynecol. 91, 349–354 (1998). · doi:10.1016/s0029-7844(97)00668-6
  27. Gitsch, G., Hanzal, E., Jensen, D. & Hacker, N. F. Endometrial cancer in premenopausal women 45 years and younger. Obstet. Gynecol. 85, 504–508 (1995). · doi:10.1016/0029-7844(95)00001-8
  28. Chretien, M. L. et al. Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients. Haematologica 99, 1236–1238 (2014). · doi:10.3324/haematol.2013.098608
  29. Ramai, D. et al. Early- and late-onset pancreatic adenocarcinoma: a population-based comparative study. Pancreatology 21, 124–129 (2021). · doi:10.1016/j.pan.2020.12.007
  30. Eguchi, H. et al. Clinicopathological characteristics of young patients with pancreatic cancer: an analysis of data from pancreatic cancer registry of Japan. Pancreas Soc. Pancreas 45, 1411–1417 (2016).
  31. Shih, H. J., Fang, S. C., An, L. & Shao, Y. J. Early-onset prostate cancer is associated with increased risks of disease progression and cancer-specific mortality. Prostate 81, 118–126 (2021). · doi:10.1002/pros.24087
  32. Siegel, D. A., O’Neil, M. E., Richards, T. B., Dowling, N. F. & Weir, H. K. Prostate cancer incidence and survival, by stage and race/ethnicity – United States, 2001–2017. MMWR Morb. Mortal. Wkly. Rep. 69, 1473–1480 (2020). · doi:10.15585/mmwr.mm6941a1
  33. Sandhu, D. P., Munson, K. W., Benghiat, A. & Hopper, I. P. Natural history and prognosis of prostate carcinoma in adolescents and men under 35 years of age. Br. J. Urol. 69, 525–529 (1992). · doi:10.1111/j.1464-410x.1992.tb15602.x
  34. Zhou, Q. P., Ge, Y. H. & Liu, C. Y. Comparison of metastasis between early-onset and late-onset gastric signet ring cell carcinoma. BMC Gastroenterol. 20, 380 (2020). · doi:10.1186/s12876-020-01529-z
  35. Campbell, B. R. et al. Early onset oral tongue squamous cell carcinoma: associated factors and patient outcomes. Head. Neck 41, 1952–1960 (2019). · doi:10.1002/hed.25650
  36. Kim, T. J., Kim, E. R., Hong, S. N., Chang, D. K. & Kim, Y. H. Long-term outcome and prognostic factors of sporadic colorectal cancer in young patients: a large institutional-based retrospective study. Medicine 95, e3641 (2016). · doi:10.1097/md.0000000000003641
  37. Chou, C. L., Tseng, C. J. & Shiue, Y. L. The impact of young age on the prognosis for colorectal cancer: a population-based study in Taiwan. Jpn. J. Clin. Oncol. 47, 1010–1018 (2017). · doi:10.1093/jjco/hyx110
  38. Yang, Z. et al. Characteristics and long-term survival of colorectal cancer patients aged 44 years and younger. Clin. Transl. Oncol. 14, 896–904 (2012). · doi:10.1007/s12094-012-0876-1
  39. McMillan, D. C. & McArdle, C. S. The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up. Br. J. Cancer 101, 557–560 (2009). · doi:10.1038/sj.bjc.6605222
  40. Boyce, S. et al. Young-onset colorectal cancer in New South Wales: a population-based study. Med. J. Aust. 205, 465–470 (2016). · doi:10.5694/mja16.00237

Cited by

See all 603

Metadata

Authors
Ugai, T., Sasamoto, N., Lee, H.-Y., Ando, M., Song, M., Tamimi, R. M., Kawachi, I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., Rebbeck, T. R., & Ogino, S.
Venue
Nature Reviews Clinical Oncology
Published
2022-09-06
Volume
19
Issue
10
Pages
656-673
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W4294754495
Cited by
603
References
311
FWCI
19.74
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is early-onset cancer an emerging global epidemic? Current evidence and future implications. https://app.cochat.ai/papers/10.1038/s41571-022-00672-8
The paper
Ugai, T., Sasamoto, N., Lee, H.-Y., Ando, M., Song, M., Tamimi, R. M., Kawachi, I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., Rebbeck, T. R., & Ogino, S. (2022). Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-022-00672-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.